The 20 Best Myotonic Dystrophy Type 2 Doctors Near Me in Northville, MI

Amro Stino, MD is an Associate Professor in the Department of Neurology in the University of Michigan Medical School, Division of Neuromuscular Medicine. Dr. Stino has expertise in the treatment of neuromuscular disorders, with special clinical and research interest in the care of patients with acquired peripheral neuropathy.A native of Ann Arbor, MI and a product of Ann Arbor schools, Dr. Stino went on to pursue a Bachelor of Science degree in Brain, Behavioral, and Cognitive Sciences from the University of Michigan, Ann Arbor, which he completed in 2006. He received his medical degree from Wayne State University, School of Medicine in Detroit, MI in 2010 and completed a transitional year internship at St. Joseph Mercy Hospital, in Ann Arbor, MI. He then completed his neurology residency training at the Wayne State University, School of Medicine – Detroit Medical Center, followed by a fellowship in clinical neurophysiology / neuromuscular medicine at The Mayo Clinic in Arizona. He joined The Ohio State University faculty in 2015 as Director of the Peripheral Neuropathy Clinic and Autonomic Lab. During his time there, he oversaw expansion of diagnostic testing and clinical operations of both, helping provide more comprehensive neuropathy care for central and southern Ohio patients seeking multi-disciplinary acquired neuropathy care. He helped obtain CIDP and CMT center of excellence accreditation. He joined the University of Michigan faculty in 2019 as Director of the Peripheral Neuropathy clinic and Co-director of the Autonomic Lab. Currently, he serves as site principal investigator on multi-center studies in the realms of metabolic and autoimmune neuropathy. He is presently conducting an investigator initiated phase 1b trial on the novel use of Lenalidomide in anti-MAG neuropathy.Dr. Stino is an advocate for patient awareness and education in autoimmune neuropathy and serves as physician liaison for the GBS-CIDP foundation, with whom he was interviewed on Good Day Columbus as part of GBS-CIDP awareness month. He also takes great interest in helping patients tackle peripheral neuropathy care in an evidence based fashion, particularly as it pertains to pain control.Dr. Stino enjoys working alongside and mentoring neuromuscular fellows, neurology residents, and medical students who rotate with him in clinic or inpatient service. He serves on the Peripheral Nerve Society Junior Board, which helps organize an annual educational course for attendees. His online videos on autoimmune neuropathy, small fiber neuropathy, and postural tachycardia syndrome have been viewed by thousands.He remains a dedicated Wolverine, despite having worked down south. Dr. Stino is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Chronic Inflammatory Demyelinating Polyneuropathy, Peripheral Neuropathy, Chronic Polyradiculoneuritis, and Familial Dysautonomia. Dr. Stino is board certified in Neurology, Clinical Neurophysiology, and Electrodiagnostic Medicine.

Daniel Singer is a Neurologist practicing medicine in Farmington Hills, Michigan. He has been practicing medicine for over 29 years. Dr. Singer is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 93 other conditions, according to our data. His clinical expertise encompasses Essential Tremor, Memory Loss, Migraine, and Seizures. Dr. Singer is board certified in American Osteopathic Board Of Neurology & Psychiatry. Dr. Singer is currently accepting new patients.

Bradley Aymen is a Neurologist practicing medicine in Farmington Hills, Michigan. Dr. Aymen is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 56 other conditions, according to our data. His clinical expertise encompasses Pseudotumor Cerebri Syndrome, Increased Intracranial Pressure, Tension Headache, and Stroke. Dr. Aymen is board certified in American Osteopathic Board Of Neurology & Psychiatry. Dr. Aymen is currently accepting new patients.

William Boudouris is a Neurologist practicing medicine in Farmington Hills, Michigan. He has been practicing medicine for over 33 years. Dr. Boudouris is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 76 other conditions, according to our data. His clinical expertise encompasses Pseudotumor Cerebri Syndrome, Increased Intracranial Pressure, Multiple Sclerosis (MS), and Stroke. Dr. Boudouris is board certified in American Osteopathic Board Of Neurology & Psychiatry. Dr. Boudouris is currently accepting new patients.

Ximena Arcila is a Neurologist practicing medicine in West Bloomfield, Michigan. Dr. Arcila is rated as an Advanced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, and Gastrostomy.

Michael Hudson is a Cardiologist practicing medicine in Plymouth, Michigan. Dr. Hudson is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Pulmonary Edema, Heart Failure, Heart Attack, Angioplasty, and Cardiac Ablation.

Jeffrey Haller is a primary care provider, practicing in Pediatrics and Internal Medicine in Farmington Hills, Michigan. He has been practicing medicine for over 41 years. Dr. Haller is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Obesity in Children, Food Allergy, Hypertension, and Familial Hypertension. Dr. Haller is board certified in American Board Of Pediatrics and American Board Of Internal Medicine. Dr. Haller is currently accepting new patients.

Martin Belkin is a Neurologist practicing medicine in Farmington Hills, Michigan. He has been practicing medicine for over 30 years. Dr. Belkin is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 51 other conditions, according to our data. His clinical expertise encompasses Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Memory Loss, and Migraine. Dr. Belkin is board certified in American Osteopathic Board Of Neurology & Psychiatry. Dr. Belkin is currently accepting new patients.

Jonathan Fellows is a Neurologist practicing medicine in Farmington Hills, Michigan. He has been practicing medicine for over 30 years. Dr. Fellows is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 75 other conditions, according to our data. His clinical expertise encompasses Essential Tremor, Transient Ischemic Attack (TIA), Autosomal Dominant Partial Epilepsy with Auditory Features, and Cerebellar Degeneration. Dr. Fellows is board certified in American Osteopathic Board Of Neurology & Psychiatry. Dr. Fellows is currently accepting new patients.

Robert Pierce is a Neurologist practicing medicine in Farmington Hills, Michigan. He has been practicing medicine for over 29 years. Dr. Pierce is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Memory Loss, Seizures, Migraine, and Epilepsy. Dr. Pierce is board certified in American Osteopathic Board Of Neurology & Psychiatry. Dr. Pierce is currently accepting new patients.

Dr. Yamada has been practicing medicine and cardiology for over 20 years. She has expertise in echocardiography which has allowed her to better understand, diagnose and treat cardiac disease. Her clinical and research interests include: cardiology oncology and the relationship between cancer treatment and heart disease; the role of echocardiography in understanding different cardiac pathologies and treatments; mitral valve disease; atrial fibrillation and general cardiology. Dr. Yamada launched the Cardio-Oncology clinic at the UMHS Cardiovascular Center in 2011, after a period of training at the MD Anderson Cancer Center. In this clinic, she evaluates patients who have cancer and are either at risk, or have developed cardiac disease as a complication of cancer treatment. Her goal in this clinic is to prevent, early diagnose and treat cardiac toxicity from cancer treatment, and to optimize underlying heart condition prior to cancer therapy. Dr. Yamada is also interested in helping childhood cancer survivors prevent heart complications from cancer treatment. Dr. Yamada is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Arrhythmias, and Doxorubicin-Induced Cardiomyopathy. Dr. Yamada is board certified in Cardiovascular Disease.

Abbas Jowkar is a Neurologist practicing medicine in Plymouth, Michigan. Dr. Jowkar is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Stiff Person Syndrome, Foot Drop, Spinal and Bulbar Muscular Atrophy, and Spinal Muscular Atrophy Type 3.

Ryan Cunnane is a Cardiac Electrophysiologist and a Cardiologist practicing medicine in Canton, Michigan. Dr. Cunnane is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Arrhythmias, Paroxysmal Supraventricular Tachycardia (PSVT), Pacemaker Implantation, and Cardiac Ablation. Dr. Cunnane is currently accepting new patients.

David Green is a Neurologist practicing medicine in Commerce Township, Michigan. He has been practicing medicine for over 41 years. Dr. Green is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Generalized Tonic-Clonic Seizure, Seizures, Tension Headache, and Memory Loss. Dr. Green is board certified in American Osteopathic Board Of Neurology & Psychiatry. Dr. Green is currently accepting new patients.

Peter K. Todd, M.D., Ph.D., is an assistant professor in the Department of Neurology in the University of Michigan Medical School.Dr. Todd earned his Bachelor of Science degree in 1994 from the University of California, San Diego. He then entered the Medical Science Training Program at the University of Wisconsin at Madison, where he completed his doctorate in 2002 and medical degree in 2004. His Ph.D research focused on synaptic defects in Fragile X Syndrome, a common inherited cause of cognitive impairment in children.He completed his internship and residency at the Hospital of the University of Pennsylvania in Philadelphia. While there, he did research on the role of the ubiquitin proteasome system and autophagy in Spinal and Bulbar Muscular Atrophy, a polyglutamine disorder, and Fragile X Tremor Ataxia Syndrome (FXTAS). He came to the U-M in 2008 for a clinical and research fellowship in movement disorders and neurogenetics.Todd joined the U-M faculty in 2010 as an assistant professor in movement disorders and neurogenetics, working in the laboratory of Henry L. Paulson, M.D., Ph.D., in the Center for Neurodegenerative Research.His current research is focused on the mechanisms underlying RNA-mediated neurodegeneration in FXTAS and myotonic dystrophy, and how these mechanisms may overlap and inform our understanding of other neurodegenerative disorders. He also sees patients with movement disorders and inherited neurological disease.Dr. Todd has received several academic awards, including a Howard Hughes Undergraduate Research Fellowship, the Francis M. Forester Prize for promise as an academic neurologist, the Samuel Ziritzky Prize for most outstanding research by a neurology resident at Penn and prizes for excellence in research at the International Conference on Unstable Microsatellites in Human Disease, and the U-M neuroscience day. Most recently, Dr Todd received the S. Weir Mitchell Alliance award from the American Academy of Neurology which each year recognizes one early investigator physician scientist who has made important contributions to basic science in neurological disorders.A member of the American Medical Association and the American Academy of Neurology, he has served as an ad-hoc reviewer for the Journal of Biological Chemistry, Neurology, Proceedings of the National Academy of Sciences, Neuron, Science and Human Molecular Genetics.His bibliography includes several peer-reviewed papers, editorials, book reviews and chapters, abstracts and online. Dr. Todd is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 49 other conditions, according to our data. His clinical expertise encompasses Fragile X Syndrome, Fragile XE Syndrome, Hereditary Ataxia, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). Dr. Todd is board certified in Neurology.

Henry L. Paulson, M.D., Ph.D., is the Lucile Groff Professor of Neurology for Alzheimer's Disease and Related Disorders in the Department of Neurology at the University of Michigan. Dr. Paulson joined the U-M faculty in 2007, and he currently directs the Michigan Alzheimer’s Disease Center (MADC) and co-direct the U-M Protein Folding Diseases Initiative.Dr. Paulson received his medical degree and doctorate in Cell Biology from Yale University in 1990. He then completed a neurology residency and neurogenetics/movement disorders fellowships at the University of Pennsylvania. In 1997, he joined the Neurology faculty at the University of Iowa, where he remained until 2007.Dr. Paulson's research and clinical interests concern the causes and treatment of age-related neurodegenerative diseases, with an emphasis on polyglutamine diseases, Alzheimer's disease and frontotemporal dementia. In 1997, his lab described abnormal protein aggregates in the polyglutamine diseases, which now are recognized as a pathological hallmark in this important class of inherited diseases. Using test tube, cell-based and animal models, he has contributed to advances in the understanding of various neurodegenerative diseases. His lab also has helped pioneer the use of gene silencing methods as potential therapy for the many neurological disorders caused by toxic mutant genes.Nationally, Dr. Paulson has directed popular courses at the American Academy of Neurology meetings, serves on the scientific advisory boards of numerous disease-related national organizations, and is past Chair of the Board of Scientific Counselors at the National Institute for Neurological Disorders and Stroke at the National Institutes of Health.Among his awards, Dr. Paulson is an Ellison Medical Foundation New Scholar in Aging, a semifinalist for the W.M. Keck Foundation Young Scholars in Medical Research, and a recipient of the Paul Beeson Physician Faculty Scholar in Aging Award from the American Federation for Aging Research. Dr. Paulson is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia Type 3, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, and Drug Induced Dyskinesia. Dr. Paulson is board certified in Neurology.

Ronald Romero is a Neurologist and a Sleep Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Romero is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Obstructive Sleep Apnea, Central Sleep Apnea, CAPOS Syndrome, and Restless Legs Syndrome.

Dr. Hornyak is Medical Director of Outpatient Pediatric Rehabilitation Services. He serves on the Evidence Based Practice Committee, and chairs the Evidence Committee, for the AAPM&R. He is actively involved in medical education, serving on the steering committee of the UM Academy of Medical Educators. His teaching has been recognized with departmental (Silver Crutch x 4), medical school (inaugural League of Educational Excellence) and university (Provost’s Teaching Innovation Prize) awards. Dr. Hornyak taught the medical portion of the Team-Based Clinical Decision Making course, the first course offered at UM for Inter-professional Education. He frequently serves on graduate student committees in the UM School of Kinesiology as well. Clinically, Dr. Hornyak practices pediatric and adult PMR. Since joining UM, he has been key in the development of multi-disciplinary care clinics for children and adults with neuromuscular diseases. Dr. Hornyak is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Charcot-Marie-Tooth Disease, Hereditary Sensory Neuropathy Type 1 (HSN1), Cerebral Palsy, and Spasticity. Dr. Hornyak is board certified in Physical Medicine & Rehab.

Dr. Krater focuses his clinical care on caring for and improving quality of life of individuals with functional limitations. His philosophy for medical care is to guide patients to develop the skills and supports to access their communities, to build a life within their communities, and to live as independently as possible. Dr. Krater is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Cerebral Palsy, Spastic Diplegia Infantile Type, Spasticity, Dysferlinopathy, and Rhizotomy.

Dr. Bowman completed her residency in Physical Medicine and Rehabilitation at Wayne State University/Detroit Medical Center in 2017. She then completed a Pediatric Rehabilitation Medicine fellowship at the University of Michigan in 2019. Dr. Bowman sees pediatric patients with a variety of conditions, including TBI, SCI, Cerebral Palsy, Neuromuscular diseases, and other conditions affecting development. Dr. Bowman is rated as an Experienced provider by MediFind in the treatment of Myotonic Dystrophy Type 2. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Cerebral Palsy, Myotonia Congenita, Spasticity, and Spastic Diplegia Infantile Type.